Stocks and Investing Stocks and Investing
Wed, July 7, 2021
Tue, July 6, 2021
Mon, July 5, 2021
Fri, July 2, 2021
Thu, July 1, 2021
Wed, June 30, 2021
Tue, June 29, 2021
Mon, June 28, 2021

Geoffrey Porges Maintained (TBPH) at Buy with Decreased Target to $36 on, Jun 28th, 2021


Published on 2024-10-27 17:04:42 - WOPRAI, Geoffrey Porges
  Print publication without navigation


Geoffrey Porges of SVB Leerink, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $39 to $36 on, Jun 28th, 2021.

Geoffrey has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Geoffrey's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoffrey


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $28 on, Thursday, May 13th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $32 on, Wednesday, May 5th, 2021